Becton Dickinson And Co logo

BDX - Becton Dickinson And Co Share Price

$277.08 0.2  0.1%

Last Trade - 17/01/20

Sector
Healthcare
Size
Large Cap
Market Cap £57.38bn
Enterprise Value £71.78bn
Revenue £13.22bn
Position in Universe 140th / 6416
Bullish
Bearish
Unlock BDX Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BDX Revenue Unlock BDX Revenue

Net Income

BDX Net Income Unlock BDX Revenue

Normalised EPS

BDX Normalised EPS Unlock BDX Revenue

PE Ratio Range

BDX PE Ratio Range Unlock BDX Revenue

Dividend Yield Range

BDX Dividend Yield Range Unlock BDX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BDX EPS Forecasts Unlock BDX Revenue
Profile Summary

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Directors
Last Annual September 30th, 2019
Last Interim September 30th, 2019
Incorporated November 13, 1906
Public Since September 25, 1963
No. of Shareholders: 13,277
No. of Employees: 70,093
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 271,011,748
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BDX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BDX
Upcoming Events for BDX
Similar to BDX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.